Life SciencesImmunologyPharmacologyAllergyHypersensitivityImmunotherapyAllergen ImmunotherapyAsthma ManagementRespiratory AllergyAirway Hyperresponsiveness AssessmentAllergen Immunotherapy For AsthmaBronchial Hyperresponsiveness ReductionCold Air Challenge TestContact AllergensForced Vital Capacity ChangeHouse Dust Mite AllergensHouse Dust Mite Exposure
BACKGROUND AND OBJECTIVE: Allergic asthma is common in children, and house dust mite (HDM) is an important source of perennial allergens. Bronchial hyperresponsiveness is a functional hallmark of asthma. Specific immunotherapy (SIT) with HDM extracts were shown to decrease symptoms, but its effect on bronchial responsiveness, as measured by non-pharmacological challenges, has not been evaluated. METHODS: Twenty-six paediatric asthma patients allergic to HDM participated in this study. Fourteen patients received SIT with a HDM extract (Alavac, Bencard) for 2 years, and 12 served as controls. Bronchial responsiveness was assessed non-pharmacologically by cold dry air challenge (CACh) before and 3, 6, 12 and 24 months after SIT, and 12 months after termination of SIT. RESULTS: After 24 months, the SIT group showed a statistically significant reduction of the mean CACh-induced changes of both forced expiratory volume in one second (-21.8+/-2.7% vs. -13.7+/-2.4%; P = 0.03) and maximal expiratory flow at 25% remaining vital capacity (-48.9+/-4.9% vs. -27.9+/-6.2%; P = 0.01). In contrast, no significant changes of bronchial responsiveness were observed in the control group. In the SIT group more patients lost their bronchial hyperresponsiveness than in the control group (6/14 vs. 1/12; P<0.05). One year after terminating SIT, the treatment group showed a tendency towards returning bronchial hyperresponsiveness. CONCLUSION: These results demonstrate that during 2 years of SIT there was a reduction of bronchial hyperresponsiveness in HDM-allergic paediatric asthma patients.
28
Lung volumes and forced ventilatory flows
PH Quanjer, G J Tammeling, J. E. Cotes et al. · European Respiratory Journal · 1993 · 5.3K citations · Full text
Quanjer Ph, Tammeling Gj, Cotes Je et al. · PubMed · 1993 · 3.8K citations
Health Professions, Clinical Sciences, Internal Medicine +17
Eosinophilic Inflammation in Asthma
Jean Bousquet, Pascal Chanez, Jean Yves Lacoste et al. · New England Journal of Medicine · 1990 · 2.5K citations · Full text
International Consensus Report on Diagnosis and Treatment of Asthma.
A L Sheffer, Jean Bousquet, WW Busse et al. · PubMed · 1992 · 674 citations
CONTROLLED TRIAL OF HYPOSENSITISATION TO DERMATOPHAGOIDES PTERONYSSINUS IN CHILDREN WITH ASTHMA
J.O. Warmer, J F Soothill, Jackie F. Price et al. · The Lancet · 1978 · 344 citations